NYSE · TEVA

Teva Pharmaceutical Industries Ltd

Smart money pulse

What insiders and funds are doing

Selling Insiders: as of Nov 12 Funds: as of Jun 30, 2026

account_balance
326 funds bought, 228 sold in the quarter ended Jun 30, 2026. 88 were new holders.
info
6 real insider sales in 12 months. $7.67M in total, not counting planned sales.

−100 means everyone selling, +100 everyone buying. This is data, not advice.

How the Pulse works

Pulse runs from −100 (everyone selling) to +100 (everyone buying). Half comes from insiders: real buyers vs. real sellers in the last 90 days (Form 4). Half comes from funds: funds that bought vs. funds that sold last quarter (13F). 13F is a snapshot of long positions on the last day of the quarter, filed up to 45 days later. It does not show short positions or trades since then.

Who owns it

676 funds report owning TEVA, up from 653

Holdings as of Jun 30, 2026

New88

Added238

Held187

Trimmed163

Sold out65

Last quarter

Who bought and who sold

Migdal Insurance & Financial Holdings Ltd.

+3%

Norges Bank

New

FMR LLC

−9%

Lingotto Investment Management LLP

−27%

State Street Corp

+6%

Rubric Capital Management LP

+2%

Capital World Investors

+42%

Altshuler Shaham Ltd

+9%

Change in shares held, biggest holdings first. Bars stop at ±100%.

Insider trades · last 12 months

Real buys and sales

● Open-market buy● Open-market sale

Last 6 months. A wider screen shows 12.

Showing 6 real trades. Hidden: 6 option exercises, 1 planned 10b5-1 sale. Those happen on a schedule and say little about what an insider thinks. Bigger dot means a bigger trade.

Real trades, newest first

Nov 12 Mark Sabag See "Remarks" Open-market sale $1.97M 44,710 sh at $44.14

Nov 11 Richard Daniell EVP, Europe Commercial Open-market sale $856K 20,003 sh at $42.80

Nov 9 Richard Daniell EVP, Europe Commercial Open-market sale $1.07M 25,000 sh at $42.91

Nov 9 Amir Weiss Chief Accounting Officer Open-market sale $744K 17,289 sh at $43.04

Nov 5 Mark Sabag See "Remarks" Open-market sale $1.93M 46,000 sh at $41.93

Nov 4 Dov Bergwerk Interim Cheif Legal Officer Open-market sale $1.1M 26,260 sh at $41.72

Showing every filing. Dashed circles are routine: grants, tax withholding, option exercises and planned sales.

Congress · last 12 months

Members of Congress who traded TEVA

All Congress trades

TEVA Teva Pharmaceutical Industries Limited American Depositary Shares Alan Armstrong OK Purchase $1,001 – $15,000 Traded Mar 30, 2026 Reported Jul 21, 2026 · 113 days later

Amounts are the ranges members report, not exact amounts. Reports can come up to 45 days after the trade. From House and Senate STOCK Act reports. This is data, not advice.

Top holders

Biggest funds in TEVA

As of Jun 30, 2026

Fund	Value	Change
BlackRock, Inc.	$2.16B	−2%
Phoenix Financial Ltd.	$1.45B	Same
WCM Investment Management, LLC	$1.38B	+1%
Menora Mivtachim Holdings Ltd.	$1.35B	+1%
Migdal Insurance & Financial Holdings Ltd.	$1.32B	+3%